- Abstract Number: 1777
Broad Proteomic Analysis Reveals Top Differential Protein Modules and Functional Annotations with Clinical Traits in Juvenile Dermatomyositis (JDM) and Myositis-Specific Autoantibody (MSA) Groups
- Abstract Number: 0007
Bromodomain 2 of BET Proteins Plays a Crucial Role in Follicular/peripheral Helper T Cell and Plasma Cell Differentiation
- Abstract Number: 1013
Burden of Emergency Department Visits and Their Outcomes Among Patients with Rheumatoid Arthritis: Insights from the Nationwide Emergency Department Sample (NEDS)
- Abstract Number: 0876
C-CAR168 as a Novel Anti-CD20/BCMA Bispecific Autologous CAR-T Therapy for the Treatment of Autoimmune Diseases
- Abstract Number: 2505
C5 Signaling Pathway Genes as Key Drivers of the Pathogenesis of IgA Vasculitis?
- Abstract Number: 1430
C57BL/6.NOD-Aec1Aec2 Mice Recapitulate Sjögren’s Serology Better Than NOD.B10Sn-H2b Models and JAK Inhibitor Treatment Improves Immunoglobulins and Salivary Gland Inflammation but Not Salivary Flow in Sjögren’s Mice
- Abstract Number: 1310
Cadaver Lab Improves Rheumatology Trainees’ Skills in Identifying Joint Anatomy and Performance of Joint Procedures
- Abstract Number: 0272
Calcifications of the Transverse Ligament of the Atlas in Patients Diagnosed with Calciumpyrophosphate Crystal Arthritis – a Retrospective Observational Study
- Abstract Number: 1638
Calprotectin, a Mechanistically Informed Biomarker for Clinically Isolated Aortitis
- Abstract Number: 2375
Can Damage Items Be Graded According to Severity in a Revised Organ Damage Index for Lupus?
- Abstract Number: 1178
Can Immersive Virtual Reality Improve the Effect of Meditation for People with Fibromyalgia?
- Abstract Number: 0216
Can Immune Checkpoint Inhibitors Safely Combat Cancer in Patients with Rheumatoid Arthritis?
- Abstract Number: 0690
Can Immunosuppression or Vasodilation Prevent the Onset of Interstitial Lung Disease in Systemic Sclerosis? An Association Analysis from the EUSTAR Database
- Abstract Number: 2575
Can Immunosuppressive Therapy Be Safely Discontinued in Patients with Lupus Nephritis?
- Abstract Number: 2037
Can Tofacitinib Be the Saviour in Treatment of Refractory IgG4-Related Disease : A Multicentre Experience from India
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 181
- Next Page »